TY - JOUR
T1 - High Levels of Methylarginines Were Associated with Increased Mortality in Patients with Severe Sepsis
AU - Myglegård Mortensen, Karoline
AU - Itenov, Theis Skovsgaard
AU - Haase, Nicolai
AU - Beier Müller, Rasmus
AU - Ostrowski, Sisse Rye
AU - Johansson, Pär Ingemar
AU - Olsen, Niels Vidiendal
AU - Perner, Anders
AU - Søe-Jensen, Peter
AU - Bestle, Morten Heiberg
PY - 2016
Y1 - 2016
N2 - INTRODUCTION: Nitric oxide (NO) likely plays a pivotal role in the pathogenesis of sepsis. Arginine is a substrate for NO, whereas the methylated arginines - asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) - are endogenous byproducts of proteolysis that inhibit NO production.We investigated if high plasma levels of ADMA, SDMA and arginine/ADMA ratio were associated with 90-day mortality in patients with severe sepsis or septic shock.METHODS: We included 267 adult patients admitted to intensive care unit with severe sepsis or septic shock. The patients had previously been included in the randomized controlled trial "Scandinavian Starch for Severe Sepsis and Septic Shock (6S)". ADMA, SDMA and arginine/ADMA ratio were measured in plasma. The risk of death within 90 days were estimated in multivariate Cox regression analyses adjusted for gender, age ≥ 65 years, major cardiovascular disease, diabetes, hypertension, respiratory failure, vasopressor treatment, highest quartile of creatinine and bilirubin, and lowest quartile of platelet count. In the regression analyses missing values were estimated using multiple imputation.RESULTS: Twenty-five patients had missing data in one or more of the baseline variables and 44 patients had missing methylarginine values. Both ADMA and SDMA were independently associated with 90-day mortality (ADMA: hazard ratio 1.54; 95% CI, 1.00-2.38; p = 0.046, and SDMA: hazard ratio 1.78; 95% CI, 1.14-2.72; p = 0.011). Arginine/ADMA ratio was not associated with 90-day mortality neither in univariate nor multivariate analyses. The difference in mortality between patients with high and low ADMA was most pronounced in the first week after inclusion.CONCLUSIONS: High levels of ADMA and SDMA in plasma were associated with increased 90-day mortality in patients with severe sepsis or septic shock. Interfering with the methylarginine-NO systems may be a novel target in these patients.
AB - INTRODUCTION: Nitric oxide (NO) likely plays a pivotal role in the pathogenesis of sepsis. Arginine is a substrate for NO, whereas the methylated arginines - asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) - are endogenous byproducts of proteolysis that inhibit NO production.We investigated if high plasma levels of ADMA, SDMA and arginine/ADMA ratio were associated with 90-day mortality in patients with severe sepsis or septic shock.METHODS: We included 267 adult patients admitted to intensive care unit with severe sepsis or septic shock. The patients had previously been included in the randomized controlled trial "Scandinavian Starch for Severe Sepsis and Septic Shock (6S)". ADMA, SDMA and arginine/ADMA ratio were measured in plasma. The risk of death within 90 days were estimated in multivariate Cox regression analyses adjusted for gender, age ≥ 65 years, major cardiovascular disease, diabetes, hypertension, respiratory failure, vasopressor treatment, highest quartile of creatinine and bilirubin, and lowest quartile of platelet count. In the regression analyses missing values were estimated using multiple imputation.RESULTS: Twenty-five patients had missing data in one or more of the baseline variables and 44 patients had missing methylarginine values. Both ADMA and SDMA were independently associated with 90-day mortality (ADMA: hazard ratio 1.54; 95% CI, 1.00-2.38; p = 0.046, and SDMA: hazard ratio 1.78; 95% CI, 1.14-2.72; p = 0.011). Arginine/ADMA ratio was not associated with 90-day mortality neither in univariate nor multivariate analyses. The difference in mortality between patients with high and low ADMA was most pronounced in the first week after inclusion.CONCLUSIONS: High levels of ADMA and SDMA in plasma were associated with increased 90-day mortality in patients with severe sepsis or septic shock. Interfering with the methylarginine-NO systems may be a novel target in these patients.
U2 - 10.1097/SHK.0000000000000649
DO - 10.1097/SHK.0000000000000649
M3 - Journal article
C2 - 27206279
SN - 1073-2322
VL - 46
SP - 365
EP - 372
JO - Shock
JF - Shock
IS - 4
ER -